Jacobson Pharma Enters Agreements with Shanghai Henlius Biotech Inc. To Tap Biologics Market
- Written by Reporters
Subscribing Shanghai Henlius' Shares at a Consideration of RMB99.4 Million
HONG KONG, CHINA - Media OutReach - 20 December 2017 - Jacobson Pharma Corporation Limited ("Jacobson Group" or the "Group"; HKSE: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines,...

